59 related articles for article (PubMed ID: 29143356)
1. Transmitting and processing electronic prescriptions: experiences of physician practices and pharmacies.
Grossman JM; Cross DA; Boukus ER; Cohen GR
J Am Med Inform Assoc; 2012; 19(3):353-9. PubMed ID: 22101907
[TBL] [Abstract][Full Text] [Related]
2. Syntax Error: Variations in the Verbiage of Prescription Labels for Pediatric Liquid Medications.
Bordelon AJ; Wilson P; Book B; Baker C; Donald BJ
Cureus; 2024 Mar; 16(3):e56039. PubMed ID: 38606237
[TBL] [Abstract][Full Text] [Related]
3. Systematic review: Baclofen dosing protocols for alcohol use disorders used in observational studies.
Thompson A; Owens L; Richardson P; Pirmohamed M
Eur Neuropsychopharmacol; 2017 Nov; 27(11):1077-1089. PubMed ID: 28939163
[TBL] [Abstract][Full Text] [Related]
4. Baclofen for Alcohol Use Disorder.
Kondrad E; Bonner A; Sandhu S; Seitz K; Weldon S
Am Fam Physician; 2024 May; 109(5):463-464. PubMed ID: 38804762
[No Abstract] [Full Text] [Related]
5. Off-label prescription: developing a guideline and validating an instrument to measure physicians' and clinical pharmacists' knowledge and attitudes toward off-label medication use.
Salari P; Larijani B; Zahedi F; Noroozi M
J Diabetes Metab Disord; 2023 Dec; 22(2):1599-1608. PubMed ID: 37975085
[TBL] [Abstract][Full Text] [Related]
6. Awareness, knowledge and views of off-label prescribing in children: a systematic review.
Balan S; Hassali MA; Mak VS
Br J Clin Pharmacol; 2015 Dec; 80(6):1269-80. PubMed ID: 26314841
[TBL] [Abstract][Full Text] [Related]
7. Baclofen in the treatment of alcohol use disorder: tailored doses matter.
de Beaurepaire R; Jaury P
Alcohol Alcohol; 2024 Jan; 59(2):. PubMed ID: 38266071
[TBL] [Abstract][Full Text] [Related]
8. Off-label prescribing: a call for heightened professional and government oversight.
Dresser R; Frader J
J Law Med Ethics; 2009; 37(3):476-86, 396. PubMed ID: 19723258
[TBL] [Abstract][Full Text] [Related]
9. Deep learning application to automated classification of recommendations made by hospital pharmacists during medication prescription review.
Alkanj A; Godet J; Johns E; Gourieux B; Michel B
Am J Health Syst Pharm; 2024 May; 81(11):e296-e303. PubMed ID: 38294025
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an e-Learning Program for Community Pharmacists for Dispensing Emicizumab (Hemlibra) in France: Nationwide Cross-Sectional Study.
Chamouard V; Freyssenge J; Clairaz-Mahiou B; Ferrera Bibas F; Fraticelli L
JMIR Form Res; 2024 Apr; 8():e54656. PubMed ID: 38574351
[TBL] [Abstract][Full Text] [Related]
11. [A prescription for yourself or acquaintances, a good idea?].
van Marum RJ; Frederiks B; Metselaar S; Hugtenburg JG
Ned Tijdschr Geneeskd; 2024 May; 168():. PubMed ID: 38804995
[TBL] [Abstract][Full Text] [Related]
12. [ETHICAL PERSPECTIVES AND DILEMMAS IN PRESCRIBING AND DISPENSING MEDICINAL PRODUCTS IN ISRAEL].
Schwartzberg E; Marom E; Trainin M; Lavon O; Shani S
Harefuah; 2024 Feb; 163(2):79-84. PubMed ID: 38431854
[TBL] [Abstract][Full Text] [Related]
13. Non-medical use of baclofen: A case series and review of the literature.
Pelerin JM; Fristot L; Gibaja V; Revol B; Gillet P; Lima-Tournebize J
Therapie; 2023; 78(6):615-637. PubMed ID: 36922285
[TBL] [Abstract][Full Text] [Related]
14. Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.
Chaignot C; Zureik M; Rey G; Dray-Spira R; Coste J; Weill A
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1239-1248. PubMed ID: 30251424
[TBL] [Abstract][Full Text] [Related]
15. Safety Challenges of Using High Dose Baclofen for Alcohol Use Disorder: A Focused Review.
Rolland B; Simon N; Franchitto N
Front Psychiatry; 2018; 9():367. PubMed ID: 30186187
[TBL] [Abstract][Full Text] [Related]
16. On-the-ground application of the 'temporary recommendation for use' regulatory measure on off-label use of baclofen for alcohol dependence in France: a regional survey of community pharmacies.
Auffret M; Rolland B; Caous AS; Gaboriau L; Deheul S; Bordet R; Gautier S
Fundam Clin Pharmacol; 2018 Apr; 32(2):234-238. PubMed ID: 29143356
[TBL] [Abstract][Full Text] [Related]
17. Attitudes of community pharmacists to off-label prescribing of baclofen in Northern France.
Auffret M; Rolland B; Caous AS; Deheul S; Béné J; Cottencin O; Bordet R; Gautier S
Int J Clin Pharm; 2015 Apr; 37(2):296-9. PubMed ID: 25666941
[TBL] [Abstract][Full Text] [Related]
18. [Involvement of pharmacists in systems for supervising off-label medications: example of the CAMTEA system for the prescription of baclofen in alcohol use disorder in Northern France].
Auffret M; Rolland B; Deheul S; Lecomte L; Cottencin O; Bordet R; Gautier S;
Ann Pharm Fr; 2014 Jan; 72(1):28-32. PubMed ID: 24438666
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
